OM:HUM

Stock Analysis Report

Executive Summary

Humana AB (publ), together with its subsidiaries, provides individual and family care services for children, adolescents, and adults in Sweden, Norway, Denmark, and Finland.


Snowflake Analysis

Good value with moderate growth potential.

Share Price & News

How has Humana's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: HUM's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

9.3%

HUM

11.8%

SE Healthcare

11.7%

SE Market


1 Year Return

-44.8%

HUM

-18.8%

SE Healthcare

-9.7%

SE Market

Return vs Industry: HUM underperformed the Swedish Healthcare industry which returned -18.8% over the past year.

Return vs Market: HUM underperformed the Swedish Market which returned -9.7% over the past year.


Shareholder returns

HUMIndustryMarket
7 Day9.3%11.8%11.7%
30 Day-19.9%-22.0%-16.3%
90 Day-36.5%-28.4%-21.1%
1 Year-44.1%-44.8%-17.9%-18.8%-7.1%-9.7%
3 Year-45.1%-46.7%-47.6%-50.0%2.2%-12.9%
5 Yearn/a78.1%50.2%10.1%-13.0%

Price Volatility Vs. Market

How volatile is Humana's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Humana undervalued compared to its fair value and its price relative to the market?

10.92x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: HUM (SEK38.65) is trading above our estimate of fair value (SEK37.96)

Significantly Below Fair Value: HUM is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: HUM is good value based on its PE Ratio (10.9x) compared to the Healthcare industry average (17x).

PE vs Market: HUM is good value based on its PE Ratio (10.9x) compared to the Swedish market (14.3x).


Price to Earnings Growth Ratio

PEG Ratio: HUM is good value based on its PEG Ratio (0.7x)


Price to Book Ratio

PB vs Industry: HUM is good value based on its PB Ratio (0.9x) compared to the SE Healthcare industry average (1.3x).


Next Steps

Future Growth

How is Humana forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

15.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HUM's forecast earnings growth (15.6% per year) is above the savings rate (-0.4%).

Earnings vs Market: HUM's earnings (15.6% per year) are forecast to grow faster than the Swedish market (7.9% per year).

High Growth Earnings: HUM's earnings are forecast to grow, but not significantly.

Revenue vs Market: HUM's revenue (5.3% per year) is forecast to grow faster than the Swedish market (4.1% per year).

High Growth Revenue: HUM's revenue (5.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HUM's Return on Equity is forecast to be low in 3 years time (13%).


Next Steps

Past Performance

How has Humana performed over the past 5 years?

29.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HUM has high quality earnings.

Growing Profit Margin: HUM's current net profit margins (2.5%) are lower than last year (3.7%).


Past Earnings Growth Analysis

Earnings Trend: HUM's earnings have grown significantly by 29.8% per year over the past 5 years.

Accelerating Growth: HUM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: HUM had negative earnings growth (-23.6%) over the past year, making it difficult to compare to the Healthcare industry average (-25.3%).


Return on Equity

High ROE: HUM's Return on Equity (8.1%) is considered low.


Next Steps

Financial Health

How is Humana's financial position?


Financial Position Analysis

Short Term Liabilities: HUM's short term assets (SEK1.8B) do not cover its short term liabilities (SEK2.2B).

Long Term Liabilities: HUM's short term assets (SEK1.8B) do not cover its long term liabilities (SEK3.7B).


Debt to Equity History and Analysis

Debt Level: HUM's debt to equity ratio (103%) is considered high.

Reducing Debt: HUM's debt to equity ratio has reduced from 172.3% to 103% over the past 5 years.

Debt Coverage: HUM's debt is well covered by operating cash flow (26.6%).

Interest Coverage: HUM's interest payments on its debt are well covered by EBIT (3.1x coverage).


Balance Sheet

Inventory Level: HUM has a high level of physical assets or inventory.

Debt Coverage by Assets: HUM's debt is not covered by short term assets (assets are 0.8x debt).


Next Steps

Dividend

What is Humana's current dividend yield, its reliability and sustainability?

1.81%

Current Dividend Yield


Upcoming Dividend Payment


Dividend Yield vs Market

Notable Dividend: HUM's dividend (1.81%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (2.03%).

High Dividend: HUM's dividend (1.81%) is low compared to the top 25% of dividend payers in the Swedish market (6.45%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, HUM has been paying a dividend for less than 10 years.

Growing Dividend: HUM's dividend payments have increased, but the company has only paid a dividend for 3 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (19.8%), HUM's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: HUM's dividends in 3 years are forecast to be well covered by earnings (27% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.2yrs

Average management tenure


CEO

Rasmus Nerman (41yo)

5.17s

Tenure

kr3,604,000

Compensation

Mr. Rasmus Nerman has been Chief Executive Officer and President of Humana AB since 2015. Mr. Nerman served as Deputy Chief Executive Officer of Humana. He served as Business Area Manager in Humana Individ ...


CEO Compensation Analysis

Compensation vs Market: Rasmus's total compensation ($USD0.00) is below average for companies of similar size in the Swedish market ($USD531.04K).

Compensation vs Earnings: Rasmus's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Rasmus Nerman
CEO & President5.17yrskr3.60m0.32% SEK6.5m
Ulf Bonnevier
Deputy CEO & CFO8.17yrsno data0.32% SEK6.5m
Anna Sönne
Head of Investor Relationsno datano datano data
Helena Pharmanson
Director of Marketing & Communication10.17yrsno data0.18% SEK3.7m
Anna Skablova
Director of Human Resource3.17yrsno datano data
Johanna Rastad
Head of Business Development2.17yrsno datano data

5.2yrs

Average Tenure

49yo

Average Age

Experienced Management: HUM's management team is seasoned and experienced (5.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Per Granath
Director14.17yrskr242.00k5.55% SEK114.0m
Fredrik Strömholm
Independent Director0.83yrno datano data
Sören Mellstig
Chair of the Board0.83yrno datano data
Kirsi Komi
Independent Director3.17yrskr155.00k0.012% SEK251.0k
Magdalena Gerger
Independent Director0.83yrno datano data
Monica Lingegård
Independent Director3.17yrskr249.00k0.0028% SEK57.9k

2.0yrs

Average Tenure

56.5yo

Average Age

Experienced Board: HUM's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: HUM insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Humana AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Humana AB (publ)
  • Ticker: HUM
  • Exchange: OM
  • Founded: 2001
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: kr2.054b
  • Shares outstanding: 53.14m
  • Website: https://www.humana.se

Number of Employees


Location

  • Humana AB (publ)
  • Warfvinges väg 39
  • 7th floor
  • Stockholm
  • Stockholm County
  • 112 51
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HUMOM (OMX Nordic Exchange Stockholm)YesOrdinary B SharesSESEKMar 2016
47HDB (Deutsche Boerse AG)YesOrdinary B SharesDEEURMar 2016
HUMSBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary B SharesGBSEKMar 2016
0RF7LSE (London Stock Exchange)YesOrdinary B SharesGBSEKMar 2016

Biography

Humana AB (publ), together with its subsidiaries, provides individual and family care services for children, adolescents, and adults in Sweden, Norway, Denmark, and Finland. The company operates through four segments: Individual & Family, Personal Assistance, Elderly Care, and Other Nordics. The Individual & Family segment provides care and treatment in psychiatry and psychosocial change processes through residential care homes, temporary and regular family homes, special service housing, outpatient care and assisted living homes, and specially adapted housing. The Personal Assistance segment provides care services and assistance to individuals with functional impairments. The Elderly Care segment consists of elderly housing, as well as provides day care, flats adapted for the elderly, meeting places, and family member services. The Other Nordics segment provides care and treatment for children, adolescents, and adults by offering various forms of housing, family homes, outpatient care and other support services; and offers personal assistance and special services housing. Humana AB (publ) was founded in 2001 and is headquartered in Stockholm, Sweden. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/03/30 23:08
End of Day Share Price2020/03/30 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.